据彭博社报道，欧洲药品管理局建议将CSL Ltd.的药物Tavneos撤出市场，称其获批依据的数据据称存在不正确和误导性。
此举令其美国制造商安进公司（Amgen Inc.）面临更大压力。
欧洲药监局建议撤市CSL药物Tavneos
2026-06-26 12:47:54
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
美国5月商品贸易逆差初值1058亿美元
